Trelagliptin succinate is the world's first weekly oral DPP 4 inhibitors, used in type 2 diabetes, this product is a weekly dipeptide base peptidase IV (DPP - 4) inhibitors, through selective, sustained suppression DPP - 4, control blood sugar levels. DPP - 4 is an enzyme that can cause intestinal insulin, glucagon like peptide 1 (glp-1) promote insulin and glucose dependence polypeptide (GIP) inactivation, and these two im down insulin plays an important role in regulating blood sugar. Inhibiting dd-4 can increase blood glucose levels dependent on insulin secretion, which can control blood glucose levels.
We can supply free sample based on your requirements and we also have good after-sales system to make sure satisfied purchase in China.
